192 related articles for article (PubMed ID: 21562143)
1. Effect of low-GDP bicarbonate-lactate-buffered peritoneal dialysis solutions on plasma levels of adipokines and gut appetite-regulatory peptides. A randomized crossover study.
Rodríguez-Carmona A; Pérez-Fontán M; Guitián A; Peteiro J; García-Falcón T; López-Muñiz A; García-Buela J; Cordido F
Nephrol Dial Transplant; 2012 Jan; 27(1):369-74. PubMed ID: 21562143
[TBL] [Abstract][Full Text] [Related]
2. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
Fusshoeller A; Plail M; Grabensee B; Plum J
Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
[TBL] [Abstract][Full Text] [Related]
4. Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study.
Pajek J; Kveder R; Bren A; Gucek A; Bucar M; Skoberne A; Waniewski J; Lindholm B
Nephrol Dial Transplant; 2009 May; 24(5):1617-25. PubMed ID: 19066345
[TBL] [Abstract][Full Text] [Related]
5. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
[TBL] [Abstract][Full Text] [Related]
6. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
7. The effect of pH-neutral peritoneal dialysis fluids on adipokine secretion from cultured adipocytes.
Teta D; Maillard M; Tedjani A; Passlick-Deetjen J; Burnier M
Nephrol Dial Transplant; 2007 Mar; 22(3):862-9. PubMed ID: 17132702
[TBL] [Abstract][Full Text] [Related]
8. Short-term regulation of peptide YY secretion by a mixed meal or peritoneal glucose-based dialysate in patients with chronic renal failure.
Pérez-Fontán M; Cordido F; Rodríguez-Carmona A; Penín M; Díaz-Cambre H; López-Muñiz A; Sangiao-Alvarellos S; García-Buela J
Nephrol Dial Transplant; 2008 Nov; 23(11):3696-703. PubMed ID: 18503008
[TBL] [Abstract][Full Text] [Related]
9. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis.
Pérez-Fontán M; Cordido F; Rodríguez-Carmona A; Peteiro J; García-Naveiro R; García-Buela J
Nephrol Dial Transplant; 2004 Aug; 19(8):2095-100. PubMed ID: 15187192
[TBL] [Abstract][Full Text] [Related]
10. The effect of bicarbonate peritoneal dialysis solutions on cardiac structural and functional alterations.
Theodoridis M; Tziakas D; Passadakis P; Kantartzi K; Roumeliotis A; Thodis E; Vargemezis V
Nephrol Dial Transplant; 2011 Dec; 26(12):4061-7. PubMed ID: 21543656
[TBL] [Abstract][Full Text] [Related]
11. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
[TBL] [Abstract][Full Text] [Related]
12. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.
Haas S; Schmitt CP; Arbeiter K; Bonzel KE; Fischbach M; John U; Pieper AK; Schaub TP; Passlick-Deetjen J; Mehls O; Schaefer F
J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742
[TBL] [Abstract][Full Text] [Related]
13. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
14. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
[TBL] [Abstract][Full Text] [Related]
15. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
[TBL] [Abstract][Full Text] [Related]
16. Free water transport in children on peritoneal dialysis is higher with more biocompatible dialysis solutions, higher with older age and declines with time.
Raaijmakers R; Coester A; Smit W; Krediet RT; Schröder CH
Nephrol Dial Transplant; 2012 Mar; 27(3):1183-90. PubMed ID: 21771747
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin plasma levels and appetite in peritoneal dialysis patients.
Aguilera A; Cirugeda A; Amair R; Sansone G; Alegre L; Codoceo R; Bajo MA; del Peso G; Díez JJ; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2004; 20():194-9. PubMed ID: 15384825
[TBL] [Abstract][Full Text] [Related]
18. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
19. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
20. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
